1. Home
  2. PUK vs ZTS Comparison

PUK vs ZTS Comparison

Compare PUK & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prudential Public Limited Company

PUK

Prudential Public Limited Company

HOLD

Current Price

$25.24

Market Cap

31.2B

Sector

Finance

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$70.74

Market Cap

29.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUK
ZTS
Founded
1848
1952
Country
Hong Kong
United States
Employees
N/A
14500
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
29.0B
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
PUK
ZTS
Price
$25.24
$70.74
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
★ $154.18
AVG Volume (30 Days)
890.5K
★ 3.2M
Earning Date
03-26-2026
05-07-2026
Dividend Yield
1.68%
★ 1.86%
EPS Growth
N/A
★ 10.05
EPS
N/A
★ 3.08
Revenue
N/A
★ $9,467,000,000.00
Revenue This Year
N/A
$5.63
Revenue Next Year
$8.92
$4.77
P/E Ratio
$23.76
★ $22.83
Revenue Growth
N/A
★ 2.28
52 Week Low
$24.61
$69.93
52 Week High
$34.03
$148.79

Technical Indicators

Market Signals
Indicator
PUK
ZTS
Relative Strength Index (RSI) 30.09 38.66
Support Level $24.61 N/A
Resistance Level $28.44 $78.20
Average True Range (ATR) 0.35 1.58
MACD -0.14 -0.29
Stochastic Oscillator 7.36 23.48

Price Performance

Historical Comparison
PUK
ZTS

About PUK Prudential Public Limited Company

Originally established in 1848 as the Prudential Mutual Assurance, Investment, and Loan Association, Prudential has changed a lot since. Set up to sell life insurance and loans to the middle class, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life around 1985. During its time as owner of Jackson, Prudential focused on building a simple chassis-style product portfolio that allowed customers to choose from a variety of add-ons. The company also became renowned for its focus on building the internal capabilities required to support its strong product offerings, including compelling technology and a large well-trained wholesale salesforce.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: